114 related articles for article (PubMed ID: 23899053)
1. Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt.
Yehia M; El-Khayat W; Kortam A; Mowafy AH; Aziz Khalifa AA; Awad A; Khattab S
Curr Med Res Opin; 2013 Nov; 29(11):1429-34. PubMed ID: 23899053
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
[TBL] [Abstract][Full Text] [Related]
3. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
Welcker JT; Nawroth F; Bilger W
Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
[TBL] [Abstract][Full Text] [Related]
4. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
[TBL] [Abstract][Full Text] [Related]
5. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
[TBL] [Abstract][Full Text] [Related]
6. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
Porter R; Kissel C; Saunders H; Keck C
Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
[TBL] [Abstract][Full Text] [Related]
7. A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study.
Choi BC; Zhou C; Ye H; Sun Y; Zhong Y; Gong F; Sini I; Abramova N; Longobardi S; Hickey M; D'Hooghe T
Reprod Biol Endocrinol; 2022 Jan; 20(1):15. PubMed ID: 35039049
[TBL] [Abstract][Full Text] [Related]
8. Patient evaluation of the redesigned follitropin alfa pen injector.
Schertz J; Worton H
Expert Opin Drug Deliv; 2017 Apr; 14(4):473-481. PubMed ID: 28140682
[TBL] [Abstract][Full Text] [Related]
9. The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing.
Schertz JC; Saunders H; Hecker C; Lang B; Arriagada P
Expert Opin Drug Deliv; 2011 Sep; 8(9):1111-20. PubMed ID: 21843107
[TBL] [Abstract][Full Text] [Related]
10. Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey.
Schertz J; Worton H
Expert Opin Drug Deliv; 2018 May; 15(5):435-442. PubMed ID: 29521156
[TBL] [Abstract][Full Text] [Related]
11. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment.
Jeannerot F; Stüdeli T; Gunther-LaVergne L; Hirning D; Schertz J
Expert Opin Drug Deliv; 2016 Sep; 13(9):1221-9. PubMed ID: 27329677
[TBL] [Abstract][Full Text] [Related]
12. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments.
Pang SC
Expert Rev Med Devices; 2005 Jan; 2(1):27-32. PubMed ID: 16293025
[TBL] [Abstract][Full Text] [Related]
13. Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jan; 14():1. PubMed ID: 26733057
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
[TBL] [Abstract][Full Text] [Related]
18. US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use.
Mahony M; Dwyer A; Barkume R; Strochlic A; Jeannerot F; Stüdeli T
Expert Opin Drug Deliv; 2018 Jan; 15(1):5-15. PubMed ID: 29198148
[TBL] [Abstract][Full Text] [Related]
19. [Ovarian stimulation with gonadotrophins in patients with polycystic ovary syndrome].
Isnard V; Paillet S; Patin V; Lesourd-Pontonnier F; Pasquier-Pelletier M; Dewailly D
Gynecol Obstet Fertil Senol; 2019 Jan; 47(1):44-53. PubMed ID: 30573426
[TBL] [Abstract][Full Text] [Related]
20. Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.
Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G
Patient Prefer Adherence; 2014; 8():813-26. PubMed ID: 24940048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
